Y Totani

662 total citations
21 papers, 523 citations indexed

About

Y Totani is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Y Totani has authored 21 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Y Totani's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Medical Imaging Techniques and Applications (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Y Totani is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Medical Imaging Techniques and Applications (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Y Totani collaborates with scholars based in Japan and United States. Y Totani's co-authors include Takeshi Ishizaki, Isamu Miyamori, Shingo Ameshima, Yoshiki Demura, Yoshiharu Yonekura, Shiro Mizuno, Tatsuro Tsuchida, Masato Sasaki, Akihito Yokoyama and Yukihiko Sugiyama and has published in prestigious journals such as European Respiratory Journal, Cancer Chemotherapy and Pharmacology and Respirology.

In The Last Decade

Y Totani

17 papers receiving 513 citations

Peers

Y Totani
Comparison fields: 5 of 64
  • Pulmonary and Respiratory Medicine 375
  • Radiology, Nuclear Medicine and Imaging 125
  • Physiology 80
  • Epidemiology 65
  • Oncology 63
Replace Alfred E. Jones with:
Alfred E. Jones United States
Roy Reeve United Kingdom
Bernard Duysinx Belgium
P. Skaarup Denmark
Hiromasa Harada Japan
S. F. Grebe Germany
Woo Kyung Chung South Korea
P. H. Cox Netherlands
Weimin Li China
Michael A. Samuels United States
Alfred E. Jones United States View profile →
Citations per field, relative to Y Totani
Y Totani · 1×
Citations per year, relative to Y Totani
Y Totani · 1×

Countries citing papers authored by Y Totani

Since Specialization
Citations

This map shows the geographic impact of Y Totani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Totani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Totani more than expected).

Fields of papers citing papers by Y Totani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Totani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Totani. The network helps show where Y Totani may publish in the future.

Co-authorship network of co-authors of Y Totani

This figure shows the co-authorship network connecting the top 25 collaborators of Y Totani. A scholar is included among the top collaborators of Y Totani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Totani. Y Totani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 29
2
[The relationships between initial clinical features and prognosis in 14 cases of diffuse alveolar hemorrhage syndrome].
0
3
[A case of advanced small cell lung cancer complicated by chronic renal failure treated with amrubicin].
2
4 222
5
[Clinical characterization of CA19-9 in patients with interstitial pneumonia showing pathological nonspecific interstitial pneumonia pattern].
6
6
18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax.
163
7
[A case of cutaneous tuberculosis under steroid & immunosuppressant therapy for dermatomyositis].
2
8
[Clinical characterization of interleukin-8 in patients with idiopathic pulmonary fibrosis].
4
9 1
10
Angiotensin-converting enzyme inhibitors and probucol suppress the time-dependent increase in urinary Type IV collagen excretion of Type II diabetes mellitus patients with early diabetic nephropathy.
16
11
[A case of lymphocytic interstitial pneumonia with Sjögren's syndrome and systemic lupus erythematosus in which human herpes virus-6 infection was the suspected pathogen].
6
12 37
13
[Neurally mediated syncope in association with small cell lung carcinoma].
3
14
[Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer].
2
15
[The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
4
16
[Silicosis characterized by increasing serum CA 19-9 in parallel with progression of lung fibrosis].
3
17 1
18 0
19 18
20
[Basic and clinical studies of measurement of neuron-specific enolase (NSE) by radioimmunoassay].
0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026